UAE Stem Cell/Cord Blood Banking Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stem Cell/ Cord Blood Banking is expanding as a result of increase in healthcare and growing awareness among people. This demand is fueling the development of market for Stem Cell/Cord Blood Banking. Some of the key players in the global Stem Cell/Cord Blood Banking Market include CBR Systems, Inc., Cordlife, Cryo-Cell International, Inc., ViaCord, Cryo-Save, LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt. Ltd., Global Cord Blood Corporation, Smart Cells International Limited, and Vita 34 International.
UAE Stroke Management and Care Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stroke Management and Care is growing as a result of rising prevalence of cardiovascular diseases, growing geriatric population, and advancements in technology. This demand is fueling the development of better care and management for stroke. Some of the key players in the global Stroke Management and Care Market include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Merck & Co., GE Healthcare, Siemens AG, Cardinal Health Inc., GlaxoSmithKline Plc, and Medtronic Plc.
UAE Synthetic Biology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Synthetic Biology is expanding as a result of rising demand for advancement in gene editing technology and genetic engineering in both developed and developing nations. This demand is fueling the development of better devices and methods for synthetic biology. Some of the key players in the global synthetic biology Market include Bota Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.; Scarab Genomics, LLC; Synthego; Synthetic Genomics Inc.; and Thermo Fisher Scientific, Inc.
UAE Thrombocytopenia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Thrombocytopenia is expanding as a result of increasing prevalence of thrombocytopenia and development of new treatment options. This demand is fueling the development of better devices and methods for the early and accurate diagnosis and treatment of Thrombocytopenia. Some of the key players in the global Thrombocytopenia Market include Sanofi, Principia Biopharma, Baxalta, Takeda, Argenx, Millennium Pharmaceuticals, Biotest, GC Pharma, Genosco (Subsidiary of Oscotec), Rigel Pharmaceuticals, Kissei Pharmaceutical, Shionogi & Co., Ltd, Amgen, Novartis, and Zenyaku Kogyo.
UAE Ultrasonic Technology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ultrasonic Technology is expanding as a result of rising chronic diseases and innovations in healthcare. This demand is fueling the growth of ultrasonic technology for the early detection and accurate diagnosis of various disease. Some of the key players in the global Ultrasonic Technology Market include Advanced Sonics, LLC, Crest Ultrasonics Corp., DPR Ultrasonic Technologies, Emerson Electric Co. (Branson), International Ultrasonic Technologies, Mosca GmbH, MS Industries AG, Sonotronic Nagel GmbH, Telsonic AG, and Ultrasonic Technologies, Inc.
UAE Urgent Care Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Urgent Care Center is expanding as a result of favorable government policies and increasing prevalence of chronic diseases and accidents. This demand is fueling the development of better infrastructures and facilities for urgent care center. Some of the key players in the global Urgent Care center market include Concentra, Inc.; American Family Care; CityMD Urgent Care; MedExpress Urgent Care; NextCare Urgent Care; Tenet Health Urgent Care; FastMed Urgent Care; Ascension Health Urgent Care; WellNow Urgent Care; Sutter Health; Aurora Urgent Care; and Intuitive Health.
UAE DNA Sequencing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for DNA Sequencing is expanding as a result of advances in DNA Sequencing technology and increased applications in clinical diagnosis drug discovery. This is raising the demand for the market and is leading to increased investment in research & development for DNA Sequencing. Some of the key players in the global DNA Sequencing Market include Aglient Technologies, Illumina, Inc., Hoffmann-La Roche Ltd., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Macrogen, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetic, and Pacific Biosciences.
The UAE Robotic Surgery Service market size was valued at $21 Mn in 2022 and is estimated to expand at a CAGR of 20.3% from 2022-30 and will reach $94 Mn in 2030. The market will grow due to the growing patient population and greater usage of sophisticated automated surgical equipment. The market is segmented by product and service type, application type, and end user. Some of the major players are Dubai Robotics (UAE), Axiom Robotics (UAE), Emirates (UAE), Next Future Transportation (UAE), Adarma (UAE), and others.
The UAE Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 5.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The UAE Alexipharmic Drugs market will grow because of growing awareness about the benefits of alexipharmic drugs among healthcare professionals and patients. The key market players are Julphar (UAE), Neopharma (UAE), Global Pharma (UAE), Pfizer Inc., and others.
The UAE Diagnostic Imaging Services market size was valued at $2.62 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $4.15 Bn in 2030. The market is segmented by product, application, and end user. The UAE Diagnostic Imaging Services market will grow the prevalence of chronic diseases is rising, demand for minimally invasive operations is rising. The key market players are Emirates Hospitals Group (UAE), Neusoft Medical Systems Middle East FZ LLC (UAE), Emirates Healthcare Group LLC (UAE), NMC Health Plc (UAE), Gulf Imaging and Radiology (UAE), and others.
By 2030, it is anticipated that the UAE Dermatology drugs market will reach a value of $207.47 Mn from $85 Mn in 2022, growing at a CAGR of 11.8% during 2022-2030. The market is primarily dominated by local players such as Gulf Pharmaceutical Industries, Neopharma, and Julphar. The market is driven by slow research and development, increasing disease prevalence, and government regulations. The dermatology drug market in UAE is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
The UAE Electronic Health Record (EHR) market size was valued at $152 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.5% from 2022 to 2030 and will reach $552 Mn in 2030. The market is segmented by product, application, and end user. The UAE EHR market will grow due to the Increasing adoption of digital health solutions. The key market players are IDC Salud, Cegedim, Siemens Healthineers, Cerner, and others.
The UAE Dialysis Market is projected to grow from $0.581 Bn in 2022 to $1.036 Bn by 2030, registering a CAGR of 7.5% during the forecast period of 2022-2030. The increasing awareness about the importance of kidney health and the availability of treatments is also expected to drive the growth of the dialysis market in the UAE. Fresenius Medical Care is one of the leading providers of dialysis products and services in the UAE, with a significant presence in the market.
UAE clinical diagnostic market was valued at $345 Mn in 2022 and is estimated to expand at a CAGR of 7% from 2022-30 and will reach $592 Mn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Al Borg Laboratories, Aster DM, National Reference Laboratory, Fujifilm Middle Eas, Al Zahrawi Medical, Gulf Medical University, Life Medical Diagnostics, Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens F. Hoffmann-La Roche Ltd, and others.
By 2030, it is anticipated that the UAE nutrition and supplements market will reach a value of $3.94 Bn from $1.91 Bn in 2022, growing at a CAGR of 9.5% during 2022-30. The market is primarily dominated by local players such as Vitabiotics Ltd, Bayer Middle East, and Forever Living Products. The market for nutrition and supplements in the UAE is primarily driven by reimbursement scenarios, increasing consumer awareness for health and lifestyle, and international supplements business. The UAE nutrition and supplements market in UAE is segmented by Type, Product, application, and Distribution Channel.
The UAE 3D imaging market is projected to grow from $0.15 Bn in 2022 to $0.55 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. The market will be driven by expanding healthcare investments and rising demand for improved medical services. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare & Siemens Healthineers.
The UAE Diabetes Devices Market is expected to witness growth from $114 Mn in 2022 to $213 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. The high prevalence of diabetes, the quick uptake of novel products, increased R&D efforts, and the raising awareness of diabetes preventive care are some major market drivers for diabetes devices in the UAE. The market is segmented by type and by the end user. Some key players in this market include Mecomed, Pioneer Medical Supplies, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The UAE ECG Equipment Market is expected to witness growth from $45 Mn in 2022 to $84 Mn in 2030 with a CAGR of 8.30% for the forecasted year 2022-2030. One of the major reasons propelling the expansion of the ECG equipment market is the rising prevalence of cardiac diseases in the United Arab Emirates. The market is segmented by product type and by the end user. Some key players in this market include Winray, Mena Medical Supplies, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
UAE 3D printing medical device Market is expected to witness growth from $15 Mn in 2022 to $53 Mn in 2030 with a CAGR of 17.30% for the forecasted year 2022-30. Increasing demand for customized medical devices in the United Arab Emirates, technological advancements, rising healthcare spending, and rising awareness of 3D printing technology are some of the major market growth factors for makers in this sector. The market is segmented by product segmented by application, technology, and end user. Some key players in this market include Bin Ali Medical Supplies, Immensa Technology Labs, Proto21, GE Healthcare, Stryker, and Medtronic.
By 2030, it is anticipated that the UAE liver cancer therapeutics market will reach a value of $57.3 Mn from $14.7 Mn in 2022, growing at a CAGR of 18.6% during 2022-30. The liver cancer therapeutics in UAE is dominated by a few domestic pharmaceutical companies such as Neopharma, Julphar, and Medpharma. The liver cancer therapeutics market in UAE is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
By 2030, it is anticipated that the UAE Lung Cancer Therapeutics Market will reach a value of $299 Mn from $149 Mn in 2022, growing at a CAGR of 9.1% during 2022-2030. The Lung Cancer Therapeutics Market in UAE is dominated by a few domestic pharmaceutical companies such as Gulf Pharmaceutical Industries, Neopharma, and SITCO. The Lung Cancer Therapeutics Market in UAE is segmented into different types of cancer and different therapy type. Some of the major factors affecting the UAE lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
By 2030, it is anticipated that the UAE Oncology Therapeutics Market will reach a value of $1.8 Bn from $0.91 Bn in 2022, growing at a CAGR of 9.4% during 2022-2030. The Oncology Therapeutics Market in UAE is dominated by a few domestic pharmaceutical companies such as Neopharma, Medpharma, and Julphar. The Oncology Therapeutics Market in UAE is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for UAE Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
The UAE Cardiac Surgery Instruments Market is expected to witness growth from $10 Mn in 2022 to $19 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. The UAE has gained popularity as a destination for medical tourism, especially among patients seeking high-quality treatment at a lower cost. As a result, there is now greater demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Gulf Scientific Al Mazroui Medical and Chemical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
UAE anti-aging therapeutics market is projected to grow from $3 Mn in 2022 to $11 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. The market is projected to expand as a result of the growing demand for anti-aging treatments and rising disposable incomes in the UAE. The UAE anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Insilico Medicine, Kuwait Saudi Pharmaceuticals, and Alkahest are the top players in the market.
The UAE Biomaterials in Healthcare Market is expected to witness growth from $781 Mn Bn in 2022 to $2260 Mn in 2030 with a CAGR of 14.20% for the forecasted year 2022-2030. The demand for biomaterials, is rising in UAE as the population increases. As a result, there are now chances for manufacturers of biomaterials to diversify their product lines and grow their market share. The market is segmented by type and by application. Some key players in this market include: Julphar, Mena Medical Supplies, Mena Medical Supplies, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.